AHA: High Cardiovascular Health Linked to Lower Phenotypic Age
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Nov. 8, 2023 -- There is an inverse association for cardiovascular health (CVH) with phenotypic age (PhenoAge) and phenotypic age acceleration (PhenoAgeAccel), according to a study to be presented at the American Heart Association Scientific Sessions 2023, held from Nov. 11 to 13 in Philadelphia.
Rahul Hosalili, from the Columbia University Irving Medical Center in New York City, and colleagues examined the associations of CVH, based on the enhanced Life's Essential 8 (LE8) framework, with PhenoAge and PhenoAgeAccel in 6,593 men and women from the 2015 to 2018 National Health and Nutrition Examination Survey. PhenoAge was computed from nine biological markers and chronological age; the difference between PhenoAge and chronological age was PhenoAgeAccel, with higher positive values indicating faster biological aging.
The researchers found that participants with high and low CVH had negative and positive PhenoAgeAccel, respectively (−4.20 and 2.36, respectively). Lower PhenoAge and PhenoAgeAccel were seen in association with each 10-unit increase in the LE8 score (β = −4.82 and −1.80, respectively) and with high versus low CVH (β = −17.15 and −6.08, respectively). Negative PhenoAgeAccel was seen in association with being in the highest versus the lowest tertile of all LE8 metrics. Lower PhenoAgeAccel was also seen in relation to being in the highest versus the lowest tertile of physical activity, body mass index, glucose, blood lipids, and blood pressure scores.
"Greater adherence to all Life's Essential 8 metrics and improving your cardiovascular health can slow down your body's aging process and have a lot of benefits down the line," senior author Nour Makarem, Ph.D., also from the Columbia University Irving Medical Center, said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2023-11-09 03:09
Read more

- Innate Pharma Announces U.S. FDA Granted Breakthrough Therapy Designation to Lacutamab for Relapsed or Refractory Sézary Syndrome
- Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human
- Perioperative Chemo With FLOT Ups Survival in Resectable Esophageal Cancer
- 'Good' Cholesterol Could Be Bad For Glaucoma
- Guidelines Developed to Address Infections Tied to Regional Anesthesia
- FDA Approves Avtozma (tocilizumab-anoh), a Biosimilar to Actemra
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions